Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Reverse that. And I'm sure you can read well.
Don't take it personally.
Frrol has long displayed reading difficulties with material he doesn't like.
Stuff your condescension in the appropriate place.
Yo Frrol You got that one 100% correct.
John k9uwa
"Anavex's EV is now below $200MM, which is low to comps. The price will eventually recover somewhat. The Missling credibility discount will remain, but full, peer reviewed AD results will help overcome that. It's also good that we will be under a regulatory approval review this year. Treat this as what it is, an investment in a risky biotech. Ignore the fantasies and conspiracies. It's a public MB, which are often loaded with kooks and panicky amateurs."
Ah Yes Tom. I bought yesterday thought about it today and didn't. Maybe will kick self in butt next week. We will see. If it had hit 3.50 today I would have bought more. We still have the outlaw firms until mid May. And I am sure that one of these days we will rise more than enough to again be profitable. Me Real Estate holdings are WELL UP. Voted ourselves a NICE raise this week. Mailed out the new Leases.
John k9uwa
Have been here since 2015 not likely to leave anytime soon !!!
Nothing of value.
Yes, that's the definition of potentially. You missed why I mentioned that trial. Read my reply to you again. Take your time.
Realscotsmith....no, I don't know what you're saying... come again.??
You saying IPIX ?? I haven't traded it in years. Should I go look?
Hey Tom, see the old name you used to trade? Made it to the expert market…
Well, in light of all the trial data to date that has been presented so often that even I can recite it with clarity and ease. Efficacy is as efficacy is as efficacy is….! Its not about the efficacy here, its about approval and REVENUE! If Kun Jin’s presence doesnt give you and others pause as to your disbief thannothing is going to convince you that Anavex has a safe, oral, novel drug for Alzheimer’s that blows away the SOC and worth everybit of 20 billion dollars upon approval.
All that being said, YES there is a conspiracy to suppress the price when the above stands true and we sit at $3.69! Algorithms, spoofing, HFT, weighted indexes, options, naked shorting dark pools, lawsuits, and yes, delay tactics from “Dr’s” on the take. So many ways to hammer a small company until someone gets a wiff of revenue generation.
Woe to you Pharisees and Sagisees, you see and still you do not believe!
Actually that "brief cut and paste was carefully considered. I didn't want to overwhelm you with facts.
The second sentence concerns type 2 errors which may well have occurred in the pediatric Rett trial. For extra credit explain what a type 2 error is to the board.
You seem to have difficulty with the word potentially. Let me help.
Dr Sabbagh talking at the American Academy of Neurology a few days ago (he became chairman of the scientific advisory board for Anavex in Sept 2023). https://www.linkedin.com/feed/update/urn:li:activity:7185618553235013632/
Yes Blue Finch you win the low for today purchase!!
John k9uwa
Gary I am sure I have heard of OLE information being filed along with or during previous filings by companies. As to how much the regulators pay attention I would think that yes they do.
John k9uwa
Me easy to find. Thats a Federal License.
HI Gary well an interesting day it was. Not bad for a Friday. I do think at the end of the day Anavex will end up with an approved drug. As to Missling I will say this first. English is for him a Second Language. He is German. Many times when you see a pause he is doing mental translation trying to find the correct english words before he speaks. Me as a Ham Radio Operator for well over 60 years have encountered the same from MANY in the same boat when it comes to English vs their native language. Someone should have bolted solid his rock and roll office chair prior to this last presentation. Yes, I could complain about what I think he has done wrong managing Anavex? Why bother he isn't listening to us. Looks like Blue Finch wins the LOW BUY FOR TODAY. I bought yesterday so missed a few pennies. Should have bought a few more today. Didn't will see what happens Monday. Looks like we picked up around 100 viewers today of TGD's YouTube presentation. It said 156 views this morning and no it says 265 views. "Volume" up today a bit or was it "Churn" today? Perhaps right at the end of the day might have been some shorts scared enough to buy their way out of their short.
What I want to see and hear? .... TGD stating WE HAVE FILED EMA. Our FDA? They have been too busy approving the MAB's sorry I don't want brain bleeds and those drugs are not selling well. And some company out there is going to do what they can to buy as much of Anavex as they can. This by hook or crook.
John k9uwa
Have been here since 2015. Not likely to leave anytime soon.
Another week is finished. Price bled down about 80 cents from the 4.40 resistance roll over. The downwave before that was about 1 dollar , from 5.20 to 4.20 area. The patterns are discernable, and without Good news... should continue the downward selling manipulation game, as long as they can accomplish it. Now, ask yourself, is today's low at 3.60 the finished bottom target? I don't think it will be. How many more weeks or months are left for shorts and index funds to sell.Will the selling of 8 million shares become the nice falling knife to catch the bottom ? How will the bleeding down game continue in the next few weeks. Where is the overhead resistance now that would roll over and begin the next downwave... 4.00 to target 3.20 maybe. 3.90 to target 3 dollars, maybe. Etc. What would be the reason why today's low at 3.60 should hold as the great cycle bottom now. ? I don't believe it will.
Next targets to watch are the resistance roll over around 3.90- 4.05, and then the bleeding downwave resumes, target 3.40,3.30, 3.20, on to 3.00, overshoot to 2.87. The 1 dollar move from 3.90 to 2.90. Or the 75 cent move from 3.90 to 3.15 area. The magnetic target is 3 dollars. The pattern target is 2.80 area. Why 2.80 ? Because all the previous resistance peaks have centered and began tumbling, from around 6.80, 5.80, 4.80, 3.80, so I see 2.80 as a pattern /algorithm target . We are Bottom fishing . Bleeding down game continues until good news stops it. And mind the impact of index listing and rebalancing procedure. Catch the falling knives.
3.60 is not the final target bottom. (3.25/ 3.00/ 2.75) is becoming visible through the mist.
Another roll over price pattern to notice... 6.20/5.20/4.20... look at the chart... target 3.20 up next. Maybe, says the magic 🎱 ball
Oh... and what's this, about the lawsuit?
Oh, magic 8 ball, what will happen next? 😸
I hope you don't mind if I save this post and bring it up in the future.
Ohsay is as original as ever and obviously talented, I just don’t know at what.
Anavex's EV is now below $200MM, which is low to comps. The price will eventually recover somewhat. The Missling credibility discount will remain, but full, peer reviewed AD results will help overcome that. It's also good that we will be under a regulatory approval review this year.
Treat this as what it is, an investment in a risky biotech. Ignore the fantasies and conspiracies. It's a public MB, which are often loaded with kooks and panicky amateurs.
Yeah they are not paying me or providing the script these days.
Too busy to write your own material now? Have to subcontract to Kund?
As the saying goes: “You get what you pay for.”
Anavex YouTube: Noble Capital Markets Healthcare Conference - April 18 2024. Thanks to DaveV-1 for posting the embedded one; it's hard to find. The link below offers a better way to view it. It works in my browsers but not in the YouTube app.
Put https: in front of the the character string below, and paste:
//www.youtube.com/watch?v=b5uoWiBshsA&t=1779s
blue--"great close today"--was thinking the same--lots of buys right into the close--good to see especially on a Friday---bodes well for next week ???? Hoping !!!!
Good catch.
Guessing covering for the last dime.
Better neutral than exposed either side over weekend.
Profit in pocket or awaiting Monday?
I'm in the same boat with you. Adding as it bleeds down. Glad I pulled my 4 dollar bids away, now 3.60 low today, didn't reach my 3.50 target. Now I changed that bid to 3.40 and 3.30. This is heading to 3 dollars maybe next week, or early May... looking to buy larger pieces around 2.80. A veteran trader can learn to enjoy Bottom fishing.
Just don't look too much at the evaporation of the 300 thousand gain that we had 3 years ago.... we're starting over again. But now, my gold and silver holdings are up alot, that compensates for it.
Anavex isn't the source of the disappointment.
It's the freeloaders and crooks that are manipulating the market.
weee....
great close today
weee.......
Orcas. They know more than they let on.
Lucid points all....
However my initial purchases here were post COVID, and in large part based on belief, after research
I recall going to sleep the night our CEO said both endpoints were met, I'll selfishly admit to THINKING, IM RICH, then thinking about mankind..yet here I am, down 6 figures...it isn't life changing but nonetheless, disappointing
LOL.....Valiant attempt @ tin foil, school marm grading of non compliant criticism.
Perhaps your numerous maladies will allow you to survive to see a resolution of Missling’s mis adventures.
Beyond that....You are tedious.
During current circumstances - "third parties" are just trying to keep the boat afloat.
They are no threat to the algos that are colluding with major institutions.
Aliens and cowboys is another possibility.
Cossacks, I suspect. Or possibly Freemasons.
Yes. But, as I noted, directing trades back and forth between “friendly” parties is not foolproof because they can get intercepted by third parties. As a result, at some point the mm’s end up with a short position that exceeds their risk parameters and they have to reduce it. Or, their naked short position (which they are quasi-permitted to carry) time period runs out and they have to buy and deliver shares.
Who is manipulating the manipulators?
In light of the pump and dump in the entire market during COVID, I would say that this statement is nonsense:
Retail simply does not have the data to "factor those affects"(sic).
If you don't recognize this you have "unrealistic expectations".
The emotions you ascribe to me are nonsense, as is your own consistent verbal flatulence.
Whether or not to buy is a personal choice... but one must be aware of the circumstances surrounding the trade.
The action in the bull market was, in retrospect, absurd. I now realize it was a bullish paint up by the algos so that people sitting at home and having government funds donated to keep businesses closed were lured into the market by these fake bull moves.
This is numerical fact.
The entire market was pumped and then dumped with algo trading.
Don't you find the fact that the entire market was manipulated in this matter very concerning?
I believe allowing this to continue could undermine our Democracy..... perhaps it already has.
Do you really believe this is acceptable?
His "style" will have nothing to do with a need and ability.
Pumpers have some shares. (Fortnight George likely does not.) They're just foolish, and untruthful. Not all bashers have positions either. Same nonsense.
i like your post
i didn't realize this stock was over 9 just 4 months ago
looking forward to manipulation back up even more now
Manipulation with algo trading can generally only be done on a relatively transitory basis in one direction. A percentage of the attempted churn trades (collusive parties trading back and forth to each other) get intercepted by others. The interest on the short positions is another factor.
The exception is when the suppression actually damages a company’s financial position, i.e., they are forced to keep issuing shares at lower and lower prices and even sometimes run out of cash. That will not happen here because they would have to keep the price consistently suppressed for several years. Now you know why Missling always keeps a large cash cushion. He knows all too well how it works.
forget a capital raise at this price not CM style
in fact he will get the price manipulated up a lot before he goes that route
that's his style
yeah i'm calling a near bottom ( like my call means anything)
as far as the weekend
what about a reversal on monday morning and we see 3.80 ?
i'd sure be happy with that
Easy to call a $AVXL bottom, there is a new one every trading day and especially on days where Missling speaks.
That brief cut-paste is correct. Now relate that to the Excellence study. (Hint: second sentence.) Bonus: relate it to the 'potentially pivotal' Avatar trial.
Followers
|
1063
|
Posters
|
|
Posts (Today)
|
140
|
Posts (Total)
|
457206
|
Created
|
12/18/07
|
Type
|
Free
|
Moderators RedShoulder Steady_T Bourbon_on_my_cornflakes kund mike_dotcom nidan7500 |
Anavex®Life Sciences Corp. (the “Company”) is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including drug candidates to treat Alzheimer’s disease, other central nervous system (“CNS”) diseases, pain and various types of cancer. The Company’s lead compound ANAVEX®2-73 is being developed to treat Alzheimer’s disease, Parkinson’s disease and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome.
Anavex®Life Sciences’ lead drug candidate, ANAVEX®2-73, recently completed successfully a Phase 2a clinical trial for Alzheimer’s disease. ANAVEX®2-73 is an orally available drug candidate that restores cellular homeostasis by targeting sigma-1 and muscarinic receptors. Preclinical studies demonstrated its potential to halt and/or reverse the course of Alzheimer’s disease. It has also exhibited anticonvulsant, anti-amnesic, neuroprotective and anti-depressant properties in animal models, indicating its potential to treat additional CNS disorders, including epilepsy and others. The Michael J. Fox Foundation for Parkinson’s Research has awarded Anavex® a research grant to develop ANAVEX®2-73 for the treatment of Parkinson’s disease to fully fund a preclinical study, which could justify moving ANAVEX®2-73 into a Parkinson’s disease clinical trial. ANAVEX®3-71, also targeting sigma-1 and M1 muscarinic receptors, is a promising preclinical drug candidate demonstrating disease modifications against the major Alzheimer’s hallmarks in transgenic (3xTg-AD) mice, including cognitive deficits, amyloid and tau pathologies, and also with beneficial effects on neuroinflammation and mitochondrial dysfunctions.
The Company is in preparation for ANAVEX®2-73 for a Phase 2/3, placebo-controlled trial in Alzheimer’s disease as well as a Phase 2, placebo-controlled trial in Rett syndrome, for which the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) for ANAVEX®2-73 and a Phase 2, placebo-controlled trial in Parkinson’s disease.
Headquartered in New York, Anavex® Life Sciences is an American publicly traded corporation on Nasdaq quoted as AVXL
.Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |